Search research articles
Contact Us
Filters
Showing results (211-220 of 1,436) with videos related to
Page
of 144
Sort By:
Journal of the National Cancer Institute
|
September 26, 2025
RecOVARY? Using anti-Müllerian hormone to predict ovarian function after anti-HER2 therapy for early breast cancer
Lynn K Symonds, Nancy E Davidson
The Journal of Pathology
|
May 1, 1971
The handling of antigen-antibody complexes and of antigen by human peritoneal cells in vitro
A E Stuart, A E Davidson
Injury
|
May 19, 2026
Bouldering-related trauma: Injury patterns and operative burden over 10 years at a UK major trauma centre
H Jemmett, C James, E Davidson
Journal of the National Cancer Institute
|
July 22, 2023
Are we there yet? Optimal duration of endocrine therapy in women with postmenopausal early-stage hormone receptor-positive breast cancer
Lynn K Symonds, Nancy E Davidson
The Journal of Pathology
|
January 1, 1971
The human reticular cell: morphology and cytochemistry
A E Stuart, A E Davidson
Nature Reviews. Clinical Oncology
|
August 9, 2017
Breast cancer: What lies beyond APHINITY for HER2-positive breast cancer?
Sasha E Stanton, Nancy E Davidson
AACN Advanced Critical Care
|
May 7, 2016
Patient and Family Post-Intensive Care Syndrome
Judy E Davidson, Maurene A Harvey
Cancer Biology & Therapy
|
May 22, 2004
Estrogen receptor status, cell cycling and paclitaxel: looking for a "hormone"-ious explanation
Ben Ho Park, Nancy E Davidson
Obesity (Silver Spring, Md.)
|
August 18, 2025
Cancer Risk-Comparing Metabolic Bariatric Surgery and the General Population
Lance E Davidson, Ted D Adams
Biochimica Et Biophysica Acta
|
January 26, 1983
Kinetic studies on the mechanism of chorismate mutase/prephenate dehydratase from Escherichia coli K12
G S Baldwin, B E Davidson
Page
of 144
Search research articles
Search
Showing results (211-220 of 1,436) with videos related to
Sort By:
Page
of 144
Journal of the National Cancer Institute
|
September 26, 2025
RecOVARY? Using anti-Müllerian hormone to predict ovarian function after anti-HER2 therapy for early breast cancer
Lynn K Symonds, Nancy E Davidson
The Journal of Pathology
|
May 1, 1971
The handling of antigen-antibody complexes and of antigen by human peritoneal cells in vitro
A E Stuart, A E Davidson
Injury
|
May 19, 2026
Bouldering-related trauma: Injury patterns and operative burden over 10 years at a UK major trauma centre
H Jemmett, C James, E Davidson
Journal of the National Cancer Institute
|
July 22, 2023
Are we there yet? Optimal duration of endocrine therapy in women with postmenopausal early-stage hormone receptor-positive breast cancer
Lynn K Symonds, Nancy E Davidson
The Journal of Pathology
|
January 1, 1971
The human reticular cell: morphology and cytochemistry
A E Stuart, A E Davidson
Nature Reviews. Clinical Oncology
|
August 9, 2017
Breast cancer: What lies beyond APHINITY for HER2-positive breast cancer?
Sasha E Stanton, Nancy E Davidson
AACN Advanced Critical Care
|
May 7, 2016
Patient and Family Post-Intensive Care Syndrome
Judy E Davidson, Maurene A Harvey
Cancer Biology & Therapy
|
May 22, 2004
Estrogen receptor status, cell cycling and paclitaxel: looking for a "hormone"-ious explanation
Ben Ho Park, Nancy E Davidson
Obesity (Silver Spring, Md.)
|
August 18, 2025
Cancer Risk-Comparing Metabolic Bariatric Surgery and the General Population
Lance E Davidson, Ted D Adams
Biochimica Et Biophysica Acta
|
January 26, 1983
Kinetic studies on the mechanism of chorismate mutase/prephenate dehydratase from Escherichia coli K12
G S Baldwin, B E Davidson
Page
of 144